AP2S1 and pancreatic adenocarcinoma: Multiple human (AsPC1, BxPC3, Cfpac, Panc1, and MiaPaCa-2) and mouse (Panc02) (Figure 1C) pancreas adenocarcinoma cell lines were treated with doses of sigma-2 ligand ranging from 1 to 1000 μM for 18 hours.